Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franz Hefti

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Pharmacological Research|April 27, 2019
Pharmacology of nerve growth factor and discovery of tanezumab, an anti-nerve growth factor antibody and pain therapeuticFranz Hefti
Journal of Parkinson'S Disease|June 21, 2021
Gene Therapy for Parkinson's Disease Associated with GBA1 MutationsAsa Abeliovich, Franz Hefti, Jeffrey Sevigny
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2004
Molecular basis for catecholaminergic neuron diversityJan Grimm, Anne Mueller, Franz Hefti, et al.
Alzheimer'S Research & Therapy|July 22, 2014
Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer's disease immunotherapeuticsWilliam F Goure, Grant A Krafft, Jasna Jerecic, et al.
Current Alzheimer Research|January 18, 2017
Conformation as the Therapeutic Target for Neurodegenerative DiseasesRajaraman Krishnan, Franz Hefti, Haim Tsubery, et al.
Trends in Pharmacological Sciences|April 16, 2013
The case for soluble Aβ oligomers as a drug target in Alzheimer's diseaseFranz Hefti, William F Goure, Jasna Jerecic, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 30, 2002
Caspase inhibitors attenuate 1-methyl-4-phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neuronsJames Bilsland, Sophie Roy, Steve Xanthoudakis, et al.
Journal of Medicinal Chemistry|October 21, 2011
Multidentate (18)F-polypegylated styrylpyridines as imaging agents for Aβ plaques in cerebral amyloid angiopathy (CAA)Zhihao Zha, Seok Rye Choi, Karl Ploessl, et al.
Pain Reports|June 21, 2018
First-in-human randomized clinical trials of the safety and efficacy of tanezumab for treatment of chronic knee osteoarthritis pain or acute bunionectomy painPatricia A Walicke, Franz Hefti, Roxanne Bales, et al.
Journal of Psychopharmacology (Oxford, England)|January 13, 2012
Effects of the combination of metyrapone and oxazepam on cocaine craving and cocaine taking: a double-blind, randomized, placebo-controlled pilot studyAnita S Kablinger, Marie A Lindner, Stephanie Casso, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Pharmacological Research|April 27, 2019
Pharmacology of nerve growth factor and discovery of tanezumab, an anti-nerve growth factor antibody and pain therapeuticFranz Hefti
Journal of Parkinson'S Disease|June 21, 2021
Gene Therapy for Parkinson's Disease Associated with GBA1 MutationsAsa Abeliovich, Franz Hefti, Jeffrey Sevigny
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2004
Molecular basis for catecholaminergic neuron diversityJan Grimm, Anne Mueller, Franz Hefti, et al.
Alzheimer'S Research & Therapy|July 22, 2014
Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer's disease immunotherapeuticsWilliam F Goure, Grant A Krafft, Jasna Jerecic, et al.
Current Alzheimer Research|January 18, 2017
Conformation as the Therapeutic Target for Neurodegenerative DiseasesRajaraman Krishnan, Franz Hefti, Haim Tsubery, et al.
Trends in Pharmacological Sciences|April 16, 2013
The case for soluble Aβ oligomers as a drug target in Alzheimer's diseaseFranz Hefti, William F Goure, Jasna Jerecic, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 30, 2002
Caspase inhibitors attenuate 1-methyl-4-phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neuronsJames Bilsland, Sophie Roy, Steve Xanthoudakis, et al.
Journal of Medicinal Chemistry|October 21, 2011
Multidentate (18)F-polypegylated styrylpyridines as imaging agents for Aβ plaques in cerebral amyloid angiopathy (CAA)Zhihao Zha, Seok Rye Choi, Karl Ploessl, et al.
Pain Reports|June 21, 2018
First-in-human randomized clinical trials of the safety and efficacy of tanezumab for treatment of chronic knee osteoarthritis pain or acute bunionectomy painPatricia A Walicke, Franz Hefti, Roxanne Bales, et al.
Journal of Psychopharmacology (Oxford, England)|January 13, 2012
Effects of the combination of metyrapone and oxazepam on cocaine craving and cocaine taking: a double-blind, randomized, placebo-controlled pilot studyAnita S Kablinger, Marie A Lindner, Stephanie Casso, et al.
Pageof 2